Protocol
A031704
Sponsor
ALLIANCE
Title
PD-inhibitor (nivolumab) and Ipilimumab followed by nivolumab vs. VEGF TKI cabozantinib with nivolumab: a phase III trial in metastatic untreated REnal cell cancEr (PDIGREE)
For More Information:
Click Here
Kidney (Renal) – A031704
May 1, 2023 by